CD123, the interleukin-3 receptor alpha chain (IL-3Rα), is aberrantly expressed in AML and other hematologic malignancies, such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and ALL10,11. The gene discussed is IL3RA; the disease is CD4+/CD56+ hematodermic neoplasm.